[18]
The substance in issue is fluconazole for which there is a patent. It is the name for the active raw medicinal ingredient when it becomes converted into dosage. The patent in question is a patent for a product made by a process. The process in issue is a process by which an active medicinal ingredient is made. The dosage is not relevant to that.